Handel nachbörslich: 4.44 -0.010 -0.22%

Trisalus Life Sciences Inc (TLSI)

Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten

Trisalus Life Sciences Inc (TLSI)

Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten

TriSalus Life Sciences, Inc. Announces Appointment of Riad Salem to its Scientific Advisory Board - Marketscreener.com

TriSalus Life Sciences adds oncology expert to SAB By Investing.com - Investing.com Canada

TriSalus Life Sciences adds oncology expert to SAB - Investing.com India

TriSalus Life Sciences adds oncology expert to SAB - Investing.com

TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board - Yahoo Finance

Magnetar Financial LLC Has $1.05 Million Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) - Defense World

Terrain Minerals Welcomes New Major Investor - TipRanks

TrivarX Boosts Board with Healthcare Expertise - TipRanks

TScan therapeutics director buys $26,450 in company stock By Investing.com - Investing.com UK

Progeny 3 Inc. Raises Stock Holdings in Sixth Street Specialty Lending, Inc. (NYSE:TSLX) - Defense World

940,831 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Purchased by Great Point Partners LLC - Defense World

Telesis Bio Inc (TBIO) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - ForexTV.com

TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com

Investing in Telesis Bio Inc (TBIO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Farallon Capital Management LLC Buys Shares of 2,000 TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World

Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade) - Seeking Alpha

TriSalus reports breakthrough in liver tumor treatment By Investing.com - Investing.com Canada

TriSalus reports breakthrough in liver tumor treatment - Investing.com India

Hood River Capital Management LLC Acquires New Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World

Keeping an Eye on Tourmaline Bio Inc (TRML) After Insider Trading Activity - Knox Daily

Financial Metrics Check: Traws Pharma Inc. (TRAW)’s Ratios for Trailing Twelve Months - The Dwinnex

TriSalus reports breakthrough in liver tumor treatment - Investing.com

TriSalus: PEDD method via TriNav Infusion System aided penetration of GM - TipRanks

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System - StockTitan

35,000 Shares in Trupanion, Inc. (NASDAQ:TRUP) Purchased by Dalton Investments Inc. - MarketBeat

Inspire Investing LLC Makes New $772,000 Investment in Transcat, Inc. (NASDAQ:TRNS) - MarketBeat

Texas Permanent School Fund Corp Has $1.08 Million Stake in Trupanion, Inc. (NASDAQ:TRUP) - Defense World

Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade - MarketBeat

Bank of America Raises Trupanion (NASDAQ:TRUP) Price Target to $56.00 - MarketBeat

Telesis Bio Inc (TBIO) can make a big difference with a little luck - SETE News

Highbridge Capital Management LLC Buys Shares of 214,545 TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - MarketBeat

Contrasting Cerus (NASDAQ:CERS) & TriSalus Life Sciences (NASDAQ:TLSI) - Defense World

Traws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special Meeting - MyChesCo

Blair William & Co. IL Decreases Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Ratios in Focus: Analyzing Telesis Bio Inc (TBIO)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Highbridge Capital Management LLC Invests $1.18 Million in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World

TriSalus Life Sciences (NASDAQ:TLSI) Now Covered by Analysts at Oppenheimer - Defense World

Oppenheimer Initiates Coverage of TriSalus Life Sciences (TLSI) with Outperform Recommendation - Nasdaq

Oppenheimer Initiates Coverage on TriSalus Life Sciences (NASDAQ:TLSI) - MarketBeat

Oppenheimer initiates TriSalus stock at outperform on liver cancer opportunity - Investing.com India

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Update - MarketBeat

TriSalus Life Sciences Inc (TLSI) CEO Buys Shares By GuruFocus - Investing.com Canada

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) CEO Mary T. Szela Buys 7,520 Shares - MarketBeat

TriSalus Life Sciences CEO buys $75k in company stock - Investing.com

TriSalus Life Sciences CEO buys $24,850 in company stock - Investing.com

TriSalus Life Sciences CEO buys $24,850 in company stock - Investing.com India

Trisalus Life Sciences director sells shares worth $49 - Investing.com

Trisalus Life Sciences director sells shares worth $49 By Investing.com - Investing.com Australia

Trisalus Life Sciences director sells shares worth $49 By Investing.com - Investing.com Canada

Trisalus Life Sciences director sells shares worth $49 By Investing.com - Investing.com UK

TriSalus Life Sciences (NASDAQ:TLSI) Trading 5% Higher - MarketBeat

TriSalus stock holds Buy rating with $11 target By Investing.com - Investing.com Canada

TriSalus stock holds Buy rating with $11 target - Investing.com

TriSalus stock holds Buy rating with $11 target By Investing.com - Investing.com Australia

TriSalus stock holds Buy rating with $11 target By Investing.com - Investing.com UK

TriSalus Reports Q2 2024 Financial Results and Business Update - Business Wire

Form 424B3 TriSalus Life Sciences, - StreetInsider.com

Critical Contrast: TriSalus Life Sciences (NASDAQ:TLSI) versus Dynatronics (NASDAQ:DYNT) - Defense World

Head-To-Head Review: TriSalus Life Sciences (NASDAQ:TLSI) & Nevro (NYSE:NVRO) - Defense World

TriSalus Life Sciences (TLSI) Scheduled to Post Earnings on Thursday - MarketBeat

TriSalus Life Sciences (TLSI) to Release Quarterly Earnings on Thursday - Defense World

Financial Review: TriSalus Life Sciences (NASDAQ:TLSI) & ClearPoint Neuro (NASDAQ:CLPT) - Defense World

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call - StockTitan

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call - Business Wire

SEC Form DEF 14A filed by TriSalus Life Sciences Inc. - Quantisnow

Short Interest in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) Decreases By 74.0% - Defense World

Canaccord Genuity maintains Buy on TriSalus Life Sciences stock, cites growth prospects - Investing.com

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation - Business Wire

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation - Yahoo Finance

TriSalus Life Sciences (NASDAQ:TLSI) Receives “Buy” Rating from Canaccord Genuity Group - Defense World

Ähnlich wie TLSI